Lipopolyplex-Mediated Co-Delivery of Doxorubicin and FAK siRNA to Enhance Therapeutic Efficiency of Treating Colorectal Cancer
Tumor metastasis is a major concern in cancer therapy. In this context, focal adhesion kinase (FAK) gene overexpression, which mediates cancer cell migration and invasion, has been reported in several human tumors and is considered a potential therapeutic target. However, gene-based treatment has ce...
Saved in:
Main Authors: | Tilahun Ayane Debele (Author), Chi-Kang Chen (Author), Lu-Yi Yu (Author), Chun-Liang Lo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
by: Kamila Butowska, et al.
Published: (2023) -
Strategies for Improving siRNA-Induced Gene Silencing Efficiency
by: Fatemeh Safari, et al.
Published: (2017) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012) -
Antibody-siRNA conjugates (ARC): Emerging siRNA drug formulation
by: Weiran Cao, et al.
Published: (2022) -
Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine
by: Federico Perche, et al.
Published: (2019)